Clinical Trial Update: Evaluate the Effect of Aclidinium Bromide on Long-term Cardiovascular Safety and Exacerbations in Moderate to Very Severe COPD Patients. [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluated the long-term cardiovascular safety and exacerbations of aclidinium bromide in patients with moderate to very severe COPD; results hav…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Aclidinium bromide (Aclidinium bromide)

Snippet

Sponsor: AstraZeneca | Conditions: COPD, Chronic Obstructive Pulmonary Disease | Phase 4 | Status: COMPLETED | Results posted: 2018-12-06